Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

FDA approval of new indication for Genentech's Activase

June 21, 1996

LM-AS-013 development for peripheral vascular disorders terminated

June 21, 1996

E. Merck reports fibrinogen (gpIIb/IIIa) antagonists

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Modified factor VII described for coagulation-related disorders

June 21, 1996

A02131-1: Novel PDE V inhibitor

June 14, 1996

Corvas reveals anticoagulant proteins

June 14, 1996

Thrombin/trypsin inhibitors from Oscillatoria agardhii

June 14, 1996

FDA allows initiation of clinical trials on Autologous Fibrinogen Delivery (AFD) kit

June 7, 1996

Genetics Institute readies factor IX marketing application

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...